Effects of cigarette smoking on circulating leukocytes and plasma cytokines in monozygotic twins

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 1, 2015, Pages 57-64

  Andreoli, Cristina ^a   Bassi, Antonella ^a   Gregg, Evan O ^b   Nunziata, Alfredo ^a   Puntoni, Riccardo ^c   Corsini, Emanuela ^d  

^a Engineering   (Italy)

^b ENI Limited   (United Kingdom)

^c BRITISH AMERICAN TOBACCO   (United Kingdom)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

cigarette smoking; cytokines; immunological markers; monozygotic twins

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; AUTACOID; CYTOKINE;

ADULT; ARTICLE; B LYMPHOCYTE; BASOPHIL; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; EOSINOPHIL COUNT; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MONOCYTE; MONOZYGOTIC TWINS; NATURAL KILLER CELL; NEUTROPHIL COUNT; PROTEIN BLOOD LEVEL; SMOKING; SUPPRESSOR CELL; ADVERSE EFFECTS; BLOOD; CARDIOVASCULAR DISEASE; CYTOLOGY; LEUKOCYTE; MIDDLE AGED; YOUNG ADULT;

ADULT; CARDIOVASCULAR DISEASES; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTES; MALE; MIDDLE AGED; SMOKING; TWINS, MONOZYGOTIC; YOUNG ADULT;

EID: 84916198770     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0290     Document Type: Article

References (47)

1. Brody JS, Spira A. State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proc Am Thorac Soc 2006;3:535-7.
2. Leone A. Biochemical markers of cardiovascular damage from tobacco smoke. Curr Pharm Des 2005;11:2199-208.
3. Smith CJ, Perfetti TA, King JA. Perspectives on pulmonary inflammation and lung cancer risk in cigarette smokers. Inhal Toxicol 2006;18:667-77.
4. Rüegg C. Leukocytes, inflammation, and angiogenesis in cancer: Fatal attractions. J Leukoc Biol 2006;80:682-4.
5. Rovina N, Koutsoukou A, Koulouris NG. Inflammation and immune response in COPD: Where do we stand? Mediators Inflamm 2013;2013:413735.
6. Domagala-Kulawik J, Hoser G, Droszcz P, Kawiak J, Droszcz W, Chazan R. T-cell subtypes in bronchoalveolar lavage fluid and in peripheral blood from patients with primary lung cancer. Diagn Cytopathol 2001;25:208-13.
7. Domagala-Kulawik J. Effects of cigarette smoke on the lung and systemic immunity. J Physiol Pharmacol 2008;59(Suppl 6):19-34.
8. Hoser G, Domagala-Kulawik J, Droszcz P, Droszcz W, Kawiak J. Lymphocyte subsets differences in smokers and nonsmokers with primary lung cancer: A flow cytometry analysis of bronchoalveolar lavage fluid cells. Med Sci Monit 2003;9:310-5.
9. Sopori ML, Kozak W. Immunomodulatory effects of cigarette smoke. J Neuroimmunol 1998;83:148-56.
10. Arimilli S, Damratoski BE, Prasad GL. Combustible and non-combustible tobacco product preparations differentially regulate human peripheral blood mononuclear cell functions. Toxicol In Vitro 2013;27:1992-2004.
11. Caminati A, Graziano P, Sverzellati N, Harari S. Smokingrelated interstitial lung diseases. Pathologica 2010;102: 525-36.
12. Zhu X, Gadgil AS, Givelber R, George MP, Stoner MW, Sciurba FC, et al. Peripheral T cell functions correlate with the severity of chronic obstructive pulmonary disease. J Immunol 2009;182:3270-7.
13. Atsou K, Chouaid C, Hejblum G. Simulation-based estimates of effectiveness and cost-effectiveness of smoking cessation in patients with chronic obstructive pulmonary disease. PLoS One 2011;6:e24870.
14. Wu J, Sin DD. Improved patient outcome with smoking cessation: When is it too late? Int J Chron Obstruct Pulmon Dis 2011;6:259-67.
15. Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, et al. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:822-6.
16. van Eeden SF, Sin DD. Chronic obstructive pulmonary disease: A chronic systemic inflammatory disease. Respiration 2008;75:224-38.
17. Oudijk EJ, Lammers JW, Koenderman L. Systemic inflammation in chronic obstructive pulmonary disease. Eur Respir J Suppl 2003;46:5s-13s.
18. Rudolph TK, Rudolph V, Baldus S. Contribution of myeloperoxidase to smoking-dependent vascular inflammation. Proc Am Thorac Soc 2008;1:5:820-3.
19. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
20. Goldschmidt-Clermont PJ, Dong C, Seo DM, Velazquez OC. Atherosclerosis, inflammation, genetics, and stem cells: 2012 update. Curr Atheroscler Rep 2012;14:201-10.
21. Lavi S, Prasad A, Yang EH, Mathew V, Simari RD, Rihal CS, et al. Smoking is associated with epicardial coronary endothelial dysfunction and elevated white blood cell count in patients with chest pain and early coronary artery disease. Circulation 2007;115:2621-7.
22. Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count and coronary heart disease: Implications for risk assessment. J Am Coll Cardiol 2004;44:1945-56.
23. Lee G, Walser TC, Dubinett SM. Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer. Curr Opin Pulm Med 2009;15:303-7.
24. Walser T, Cui X, Yanagawa J, Lee JM, Heinrich E, Lee G, et al. Smoking and lung cancer: The role of inflammation. Proc Am Thorac Soc 2008;5:811-5.
25. Andreoli C, Gregg EO, Puntoni R, Gobbi V, Nunziata A, Bassi A. Cross-sectional study of biomarkers of exposure and biological effect on monozygotic twins discordant for smoking. Clin Chem Lab Med 2011;49:137-45.
26. St. Charles FK, Krautter GR, Dixon M, Mariner DC. A comparison of nicotine dose estimates in smokers between filter analysis, salivary cotinine, and urinary excretion of nicotine metabolites. Psychopharmacol 2006;189:345-54.
27. Xia Y, McGuffey JE, Bhattacharyya S, Sellergren B, Yilmaz E, Wang L, et al. Analysis of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine by extraction on a molecularly imprinted polymer column and liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Anal Chem 2005;77:7639-45.
28. Pan J, Song Q, Shi H, King M, Junga H, Zhou S, et al. Development, validation and transfer of a hydrophilic interaction liquid chromatography/tandem mass spectrometric method for the analysis of the tobacco-specific nitrosamine metabolite NNAL in human plasma at low picogram per milliliter concentrations. Rapid Commun Mass Spectrom 2004;18:2549-57.
29. Altman DG. Practical statistics for medical research. London: Chapman and Hall, 1991.
30. Edwards AL. The correlation coefficient. In: An introduction to linear regression and correlation. San Francisco (CA): WH Freeman, 1976:33-46.
31. Calverley PM, Scott S. Is airway inflammation in chronic obstructive pulmonary disease (COPD) a risk factor for cardiovascular events? COPD 2006;3:233-42.
32. Smith LA, Paszkiewicz GM, Hutson AD, Pauly JL. Inflammatory response of lung macrophages and epithelial cells to tobacco smoke: A literature review of ex vivo investigations. Immunol Res 2010;46:94-126.
33. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009;360: 2445-54.
34. Stämpfli MR, Anderson GP. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol 2009;9:377-84.
35. Calapai G, Caputi AP, Mannucci C, Russo GA, Gregg E, Puntoni R, et al. Cardiovascular biomarkers in groups of established smokers after a decade of smoking. Basic Clin Pharmacol Toxicol 2009;104:322-8.
36. Roos-Engstrand E, Ekstrand-Hammarström B, Pourazar J, Behndig AF, Bucht A, Blomberg A. Influence of smoking cessation on airway T lymphocyte subsets in COPD. COPD 2009;6:112-20.
37. Hodge G, Mukaro V, Reynolds PN, Hodge S. Role of increased CD8/CD28(null) T cells and alternative co-stimulatory molecules in chronic obstructive pulmonary disease. Clin Exp Immunol 2011;166:94-102.
38. Vargas-Rojas MI, Ramírez-Venegas A, Limón-Camacho L, Ochoa L, Hernández-Zenteno R, Sansores RH. Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease. Respir Med 2011;105:1648-54.
39. Kim WD, Kim WS, Koh Y, Lee SD, Lim CM, Kim DS, et al. Abnormal peripheral blood T-lymphocyte subsets in a subgroup of patients with COPD. Chest 2002;122:437-44.
40. Tollerud DJ, Clark JW, Brown LM, Neuland CY, Mann DL, Pankiw-Trost LK, et al. The effects of cigarette smoking on T cell subsets. A population-based survey of healthy Caucasians. Am Rev Respir Dis 1989;139:1446-51.
41. Hunninghake DB. Cardiovascular disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2:44-9.
42. MacCallum PK. Markers of hemostasis and systemic inflammation in heart disease and atherosclerosis in smokers. Proc Am Thorac Soc 2005;2:34-43.
43. Robbins CS, Dawe DE, Goncharova SI, Pouladi MA, Drannik AG, Swirski FK, et al. Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness. Am J Respir Cell Mol Biol 2004;30:202-11.
44. Kode A, Yang SR, Rahman I. Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells. Respir Res 2006;7:132. Erratum in: Respir Res. 2008; 9:6.
45. Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest 1999;115:829-35.
46. Mazer SP, Rabbani LE. Evidence for C-reactive protein's role in vascular disease: Atherothrombosis, immuno-regulation and CRP. J Thromb Thrombolysis 2004;17:95-105.
47. Paffen E, DeMaat MP. C-reactive protein in atherosclerosis: A causal factor? Cardiovasc Res 2006;71:30-9.